Home
The impact of chromosomal fusions on 3D genome

The impact of chromosomal fusions on 3D genome

By May 22, 2021 Antibody, immune, Mouse monoclonal, peptide, plasmid 0 Comments
The influence of chromosomal fusions on 3D genome folding and recombination within the germ line
The spatial folding of chromosomes contained in the nucleus has regulatory results on gene expression, but the influence of genome reshuffling on this group stays unclear. Right here, we make the most of chromosome conformation seize together with single-nucleotide polymorphism (SNP) genotyping and evaluation of crossover occasions to review how the higher-order chromatin group and recombination landscapes are affected by chromosomal fusions within the mammalian germ line.
We exhibit that chromosomal fusions alter the nuclear structure throughout meiosis, together with an elevated price of heterologous interactions in main spermatocytes, and alterations in each chromosome synapsis and axis size.
These disturbances in topology have been related to modifications in genomic landscapes of recombination, leading to detectable genomic footprints. General, we present that chromosomal fusions influence the dynamic genome topology of germ cells in two methods: (i) altering chromosomal nuclear occupancy and synapsis, and (ii) reshaping landscapes of recombination.

Profiles of immune cell infiltration and immune-related genes within the tumor microenvironment of HNSCC with or with out HPV an infection

Head and neck squamous cell carcinoma (HNSCC) are the sixth commonest most cancers sort on this planet. Human papillomavirus (HPV) an infection is an rising threat issue for HNSCC. Immune infiltration of HNSCC is linked to therapeutic outcomes. This text aimed to determine whether or not variations in HPV standing have an effect on immune infiltration, molecular mechanism, and the way these outcomes fluctuate in HNSCC sufferers.
We investigated the tumor-infiltrating immune cells (TIICs) and immune-related gene variations between HPV (+) and HPV (-) HNSCC. The gene expression quantification information of HNSCC and their medical data have been obtain from the TCGA database. Immune-related genes have been linked to the ImmPort platform.
After analyzed of 22 TIICs within the HNSCC tumor atmosphere by CIBERSORT and additional evaluation, decrease reminiscence B cell and better T cell regulatory have been related with higher HPV (-) HNSCC end result, increased activated reminiscence CD4 T cell, increased T cell regulatory, and decrease activated NK cell have been linked with higher HPV (+) consequence.
We lastly acquired 5 types of immune genes (CAMP, EDNRB, NTS, CXCL9, LHB) related to HNSCC development. Larger expressions of CAMP, EDNRB, and NTS have been related to elevated total survival in HPV (-) sufferers. Larger expression of CXCL9 and decrease expression of LHB contributed to elevated total survival of HPV (+) sufferers.
There are typically discrepancies within the cell construction of TIICs and immune-related genes in HPV (-) and HPV (+) HNSCC. These variances are usually too essential for the therapeutic end result of the affected person and the event of the tumor. In particular, our pattern established these candidate immune cells and immune-related genes as candidate reservoirs for additional researches.
x-dv
x-dv

Tie2 Kinase Inhibitor
B1338-5 each
EUR 314.4

Tie2 kinase inhibitor
A5979-100 100 mg
EUR 1452
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 kinase inhibitor
A5979-25 25 mg
EUR 477.6
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 kinase inhibitor
A5979-5 5 mg
EUR 199.2
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 kinase inhibitor
A5979-5.1 10 mM (in 1mL DMSO)
EUR 536.4
Description: IC50: A reversible and selective inhibitor of Tie2 with IC50 of 0.25 M, whose selectivity is 200-fold higher than that of p38.

Tie2 kinase inhibitor
E1KS1577 10mg
EUR 1849.2

K252A (Kinase inhibitor)
SIH-455-100UG 100 µg
EUR 157.2
Description: The substance K252A is a kinase inhibitor. It is nonomuraea longicatena and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in DMSO.

K252A (Kinase inhibitor)
SIH-455-1MG 1 mg
EUR 358.8
Description: The substance K252A is a kinase inhibitor. It is nonomuraea longicatena and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in DMSO.

K252B (Kinase inhibitor)
SIH-456-100UG 100 µg
EUR 218.4
Description: The substance K252B is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (1 mg/ml) or dimethyl formamide (1 mg/ml).

K252B (Kinase inhibitor)
SIH-456-1MG 1 mg
EUR 682.8
Description: The substance K252B is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (1 mg/ml) or dimethyl formamide (1 mg/ml).

MAPKII Kinase Inhibitor
abx076811-1mg 1 mg
EUR 376.8

Sorafenib (Raf-1 kinase inhibitor)
SIH-476-10MG 10 mg
EUR 145.2
Description: The substance Sorafenib is a raf-1 kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is off white powder which is soluble inDMSO (200mg/ml) or ethanol (3mg/ml).

Sorafenib (Raf-1 kinase inhibitor)
SIH-476-50MG 50 mg
EUR 346.8
Description: The substance Sorafenib is a raf-1 kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is off white powder which is soluble inDMSO (200mg/ml) or ethanol (3mg/ml).

Tyrosine kinase inhibitor
HY-10421 25mg
EUR 459.6

Dasatinib (Kinase inhibitor)
SIH-440-25MG 25 mg
EUR 238.8
Description: The substance Dasatinib is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is crystalline solid which is soluble in DMSO (200 mg/ml), ethanol (very poorly ), and water (very poorly ).

Dasatinib (Kinase inhibitor)
SIH-440-5MG 5 mg
EUR 160.8
Description: The substance Dasatinib is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is crystalline solid which is soluble in DMSO (200 mg/ml), ethanol (very poorly ), and water (very poorly ).

IKK-? Kinase Inhibitor II
1811-1 each
EUR 189.6

IKK-? Kinase Inhibitor II
1811-5 each
EUR 574.8

RIP2 kinase inhibitor 2
HY-19761 50mg
EUR 2539.2

PP1 (Src kinase inhibitor)
SIH-469-25MG 25 mg
EUR 742.8
Description: The substance PP1 is a src kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is tan solid which is soluble in DMSO (25 mg/ml), slightly soluble in 100% ethanol.

PP1 (Src kinase inhibitor)
SIH-469-5MG 5 mg
EUR 246
Description: The substance PP1 is a src kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is tan solid which is soluble in DMSO (25 mg/ml), slightly soluble in 100% ethanol.

PP2 (Src kinase inhibitor)
SIH-470-25MG 25 mg
EUR 884.4
Description: The substance PP2 is a src kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml).

PP2 (Src kinase inhibitor)
SIH-470-5MG 5 mg
EUR 279.6
Description: The substance PP2 is a src kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml).

C16 (PKR kinase inhibitor)
SIH-498-25MG 25 mg
EUR 420
Description: The substance C16 is a pkr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is solid which is soluble in DMSO 12 mg/ml .

C16 (PKR kinase inhibitor)
SIH-498-5MG 5 mg
EUR 164.4
Description: The substance C16 is a pkr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is solid which is soluble in DMSO 12 mg/ml .

Midostaurin (Kinase inhibitor)
SIH-468-1MG 1 mg
EUR 205.2
Description: The substance Midostaurin is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (15 mg/ml), MDC (10 mg/ml), methanol (5 mg/ml) or 100% ethanol (2.5 mg/ml).

Midostaurin (Kinase inhibitor)
SIH-468-5MG 5 mg
EUR 608.4
Description: The substance Midostaurin is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white powder which is soluble in DMSO (15 mg/ml), MDC (10 mg/ml), methanol (5 mg/ml) or 100% ethanol (2.5 mg/ml).

Aurora Kinase Inhibitor 3
HY-112373 1mg
EUR 198

6BIO (PDK1 kinase inhibitor)
SIH-422-25MG 25 mg
EUR 474
Description: The substance 6BIO is a pdk1 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is dark red solid which is soluble to 10 mM in DMSO and to 10 mM in ethanol.

6BIO (PDK1 kinase inhibitor)
SIH-422-5MG 5 mg
EUR 178.8
Description: The substance 6BIO is a pdk1 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is dark red solid which is soluble to 10 mM in DMSO and to 10 mM in ethanol.

LYS6K2 (S6 kinase inhibitor)
SIH-462-25MG 25 mg
EUR 582
Description: The substance LYS6K2 is a s6 kinase inhibitor. It is synthetically produced and has a purity of 0.97. The pure substance is yellow solid which is soluble in DMSO (up to 1 mg/ml) or DMF (up to 3 mg/ml with warming).

LYS6K2 (S6 kinase inhibitor)
SIH-462-5MG 5 mg
EUR 205.2
Description: The substance LYS6K2 is a s6 kinase inhibitor. It is synthetically produced and has a purity of 0.97. The pure substance is yellow solid which is soluble in DMSO (up to 1 mg/ml) or DMF (up to 3 mg/ml with warming).

Aurora Kinase Inhibitor III
B7947-.5 500 µg
EUR 141.6
Description: Aurora Kinase Inhibitor III

Aurora Kinase Inhibitor III
B7947-1 1 mg
EUR 214.8
Description: Aurora Kinase Inhibitor III

Aurora Kinase Inhibitor III
B7947-5 5 mg
EUR 714
Description: Aurora Kinase Inhibitor III

KT5720 (PKA kinase inhibitor)
SIH-457-100UG 100 µg
EUR 246
Description: The substance KT5720 is a pka kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white powder which is soluble in methanol: clear colorless solution at 5 mg/ml.

KT5720 (PKA kinase inhibitor)
SIH-457-500UG 500 µg
EUR 682.8
Description: The substance KT5720 is a pka kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white powder which is soluble in methanol: clear colorless solution at 5 mg/ml.

ml167 (Clk4 kinase inhibitor)
SIH-505-25MG 25 mg
EUR 608.4
Description: The substance ml167 is a clk4 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white to gray to brown which is soluble in DMSO 10 mg/ml, clear .

ml167 (Clk4 kinase inhibitor)
SIH-505-5MG 5 mg
EUR 205.2
Description: The substance ml167 is a clk4 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white to gray to brown which is soluble in DMSO 10 mg/ml, clear .

GW2580 (cFMS kinase inhibitor)
SIH-449-25MG 25 mg
EUR 447.6
Description: The substance GW2580 is a cfms kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige solid which is soluble in DMSO: 10 mg/ml, clear (warmed) .

GW2580 (cFMS kinase inhibitor)
SIH-449-5MG 5 mg
EUR 168
Description: The substance GW2580 is a cfms kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige solid which is soluble in DMSO: 10 mg/ml, clear (warmed) .

PD98059 (MEK kinase inhibitor)
SIH-466-25MG 25 mg
EUR 514.8
Description: The substance PD98059 is a mek kinase inhibitor. It is synthetically produced and has a purity of ?95%. The pure substance is pale yellow solid which is soluble in DMSO (6.5 mg/ml); 25 mg/ml in anhydrous DMSO), methanol, dichlormethane and 100% ethanol (0.6 mg/ml).

PD98059 (MEK kinase inhibitor)
SIH-466-5MG 5 mg
EUR 184.8
Description: The substance PD98059 is a mek kinase inhibitor. It is synthetically produced and has a purity of ?95%. The pure substance is pale yellow solid which is soluble in DMSO (6.5 mg/ml); 25 mg/ml in anhydrous DMSO), methanol, dichlormethane and 100% ethanol (0.6 mg/ml).

AZD6244 (ERK kinase inhibitor)
SIH-495-25MG 25 mg
EUR 716.4
Description: The substance AZD6244 is a erk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in DMSO (92 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), and ethanol (<1 mg/ml at 25 °C).

AZD6244 (ERK kinase inhibitor)
SIH-495-5MG 5 mg
EUR 252
Description: The substance AZD6244 is a erk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in DMSO (92 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), and ethanol (<1 mg/ml at 25 °C).

SRPIN340 (SR kinase inhibitor)
SIH-514-25MG 25 mg
EUR 481.2
Description: The substance SRPIN340 is a sr kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble to 100 mM in DMSO and to 50 mM in 1eq. HCl.

SRPIN340 (SR kinase inhibitor)
SIH-514-5MG 5 mg
EUR 178.8
Description: The substance SRPIN340 is a sr kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble to 100 mM in DMSO and to 50 mM in 1eq. HCl.

AG1296 (PDGFR kinase inhibitor)
SIH-426-25MG 25 mg
EUR 608.4
Description: The substance AG1296 is a pdgfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white to brownish solid which is soluble in DMSO or dichloromethane.

AG1296 (PDGFR kinase inhibitor)
SIH-426-5MG 5 mg
EUR 205.2
Description: The substance AG1296 is a pdgfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white to brownish solid which is soluble in DMSO or dichloromethane.

SU1498 (VEGFR kinase inhibitor)
SIH-480-25MG 25 mg
EUR 447.6
Description: The substance SU1498 is a vegfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is solid which is soluble in DMSO .

SU1498 (VEGFR kinase inhibitor)
SIH-480-5MG 5 mg
EUR 169.2
Description: The substance SU1498 is a vegfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is solid which is soluble in DMSO .

PD325901 (MEK kinase inhibitor)
SIH-507-25MG 25 mg
EUR 554.4
Description: The substance PD325901 is a mek kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble to 25 mM in DMSO.

PD325901 (MEK kinase inhibitor)
SIH-507-5MG 5 mg
EUR 205.2
Description: The substance PD325901 is a mek kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble to 25 mM in DMSO.

PHA 665752 (MET kinase inhibitor)
SIH-421-25MG 25 mg
EUR 696
Description: The substance PHA 665752 is a met kinase inhibitor. It is synthetically produced and has a purity of >98. The pure substance is yellow solid which is soluble to 100 mM in DMSO. .

PHA 665752 (MET kinase inhibitor)
SIH-421-5MG 5 mg
EUR 231.6
Description: The substance PHA 665752 is a met kinase inhibitor. It is synthetically produced and has a purity of >98. The pure substance is yellow solid which is soluble to 100 mM in DMSO. .

A83 01 (ALK kinase inhibitor)
SIH-423-25MG 25 mg
EUR 514.8
Description: The substance A83 01 is a alk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige powder which is soluble to 50 mM in DMSO.

A83 01 (ALK kinase inhibitor)
SIH-423-5MG 5 mg
EUR 187.2
Description: The substance A83 01 is a alk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige powder which is soluble to 50 mM in DMSO.

CID 2011756 (PKD kinase inhibitor)
SIH-438-25MG 25 mg
EUR 514.8
Description: The substance CID 2011756 is a pkd kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige solid which is soluble to 50 mM in DMSO.

CID 2011756 (PKD kinase inhibitor)
SIH-438-5MG 5 mg
EUR 184.8
Description: The substance CID 2011756 is a pkd kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige solid which is soluble to 50 mM in DMSO.

KT 5823 (PKG kinase inhibitor)
SIH-458-100UG 100 µg
EUR 246
Description: The substance KT 5823 is a pkg kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (20 mg/ml), dimethyl formamide (20 mg/ml) and ethyl acetate (5 mg/ml).

KT 5823 (PKG kinase inhibitor)
SIH-458-500UG 500 µg
EUR 682.8
Description: The substance KT 5823 is a pkg kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (20 mg/ml), dimethyl formamide (20 mg/ml) and ethyl acetate (5 mg/ml).

NPC 15437 (PKC kinase inhibitor)
SIH-464-1MG 1 mg
EUR 205.2
Description: The substance NPC 15437 is a pkc kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in water, DMSO or methanol.

NPC 15437 (PKC kinase inhibitor)
SIH-464-5MG 5 mg
EUR 447.6
Description: The substance NPC 15437 is a pkc kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in water, DMSO or methanol.

Src I1 (Src kinase inhibitor)
SIH-478-25MG 25 mg
EUR 399.6
Description: The substance Src I1 is a src kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (5 mg/ml).

Src I1 (Src kinase inhibitor)
SIH-478-5MG 5 mg
EUR 158.4
Description: The substance Src I1 is a src kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (5 mg/ml).

GF109203X (PKC kinase inhibitor)
SIH-447-10MG 10 mg
EUR 306
Description: The substance GF109203X is a pkc kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is red solid which is soluble in dimethyl formamide or DMSO (10 mg/ml, warm to 40°C and vortex well).

GF109203X (PKC kinase inhibitor)
SIH-447-1MG 1 mg
EUR 178.8
Description: The substance GF109203X is a pkc kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is red solid which is soluble in dimethyl formamide or DMSO (10 mg/ml, warm to 40°C and vortex well).

Auranofin (IKK kinase inhibitor)
SIH-493-50MG 50 mg
EUR 178.8
Description: The substance Auranofin is a ikk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble in DMSO (5 mg/ml) or 100% ethanol (4 mg/ml).

LY364947 (ALK5 kinase inhibitor)
SIH-504-25MG 25 mg
EUR 474
Description: The substance LY364947 is a alk5 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow to brown solid which is soluble to 100 mM in DMSO.

LY364947 (ALK5 kinase inhibitor)
SIH-504-5MG 5 mg
EUR 184.8
Description: The substance LY364947 is a alk5 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow to brown solid which is soluble to 100 mM in DMSO.

p21/Cyclin-Dependent Kinase Inhibitor 1
MO47036 100 ul
EUR 418.8

AG 1478 (EGFR kinase inhibitor)
SIH-425-25MG 25 mg
EUR 474
Description: The substance AG 1478 is a egfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to light yellow solid which is soluble in DMSO (10 mg/ml).

AG 1478 (EGFR kinase inhibitor)
SIH-425-5MG 5 mg
EUR 184.8
Description: The substance AG 1478 is a egfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to light yellow solid which is soluble in DMSO (10 mg/ml).

AG 1517 (EGFR kinase inhibitor)
SIH-427-25MG 25 mg
EUR 541.2
Description: The substance AG 1517 is a egfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in DMSO.

AG 1517 (EGFR kinase inhibitor)
SIH-427-5MG 5 mg
EUR 192
Description: The substance AG 1517 is a egfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in DMSO.

AG 879 (NGFR kinase inhibitor)
SIH-429-25MG 25 mg
EUR 514.8
Description: The substance AG 879 is a ngfr kinase inhibitor. It is synthetically produced and has a purity of ?99%. The pure substance is yellow solid which is soluble in 100% ethanol (25 mg/ml) or DMSO (25 mg/ml).

AG 879 (NGFR kinase inhibitor)
SIH-429-5MG 5 mg
EUR 182.4
Description: The substance AG 879 is a ngfr kinase inhibitor. It is synthetically produced and has a purity of ?99%. The pure substance is yellow solid which is soluble in 100% ethanol (25 mg/ml) or DMSO (25 mg/ml).

Bml 277 (CHK2 kinase inhibitor)
SIH-436-10MG 10 mg
EUR 210
Description: The substance Bml 277 is a chk2 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (20 mg/ml) or ethanol (20 mg/ml).

Bml 277 (CHK2 kinase inhibitor)
SIH-436-50MG 50 mg
EUR 608.4
Description: The substance Bml 277 is a chk2 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (20 mg/ml) or ethanol (20 mg/ml).

GW 441756 (NGFR kinase inhibitor)
SIH-450-10MG 10 mg
EUR 279.6
Description: The substance GW 441756 is a ngfr kinase inhibitor. It is synthetically produced and has a purity of >99. The pure substance is red solid which is soluble to 15 mM in DMSO.

GW 441756 (NGFR kinase inhibitor)
SIH-450-50MG 50 mg
EUR 877.2
Description: The substance GW 441756 is a ngfr kinase inhibitor. It is synthetically produced and has a purity of >99. The pure substance is red solid which is soluble to 15 mM in DMSO.

LFM A13 (BTK kinase inhibitor)
SIH-461-25MG 25 mg
EUR 481.2
Description: The substance LFM A13 is a btk kinase inhibitor. It is synthetically produced and has a purity of ?97%. The pure substance is yellow solid which is soluble in DMSO (10 mg/ml) or ethanol (0.3 mg/ml).

LFM A13 (BTK kinase inhibitor)
SIH-461-5MG 5 mg
EUR 178.8
Description: The substance LFM A13 is a btk kinase inhibitor. It is synthetically produced and has a purity of ?97%. The pure substance is yellow solid which is soluble in DMSO (10 mg/ml) or ethanol (0.3 mg/ml).

Y 27632 (ROCK kinase inhibitor)
SIH-486-1MG 1 mg
EUR 178.8
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

Y 27632 (ROCK kinase inhibitor)
SIH-486-5MG 5 mg
EUR 393.6
Description: The substance Y 27632 is a rock kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to pale yellow powder which is soluble in DMSO (25 mg/ml), methanol (25 mg/ml), acetonitrile (<1 mg/ml), dioxan (<1 mg/ml), water (very soluble.

AG 494 (EGFR kinase inhibitor)
SIH-491-10MG 10 mg
EUR 178.8
Description: The substance AG 494 is a egfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (25 mg/ml) or 100% ethanol (25 mg/ml).

AG 494 (EGFR kinase inhibitor)
SIH-491-50MG 50 mg
EUR 481.2
Description: The substance AG 494 is a egfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (25 mg/ml) or 100% ethanol (25 mg/ml).

SR 3576 (JNK3 kinase inhibitor)
SIH-513-5MG 5 mg
EUR 298.8
Description: The substance SR 3576 is a jnk3 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off white solid which is soluble to 100 mM in DMSO.

CHIR99021 (GSK3? kinase inhibitor)
SIH-437-1MG 1 mg
EUR 151.2
Description: The substance CHIR99021 is a gsk3? kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to light brown solid which is soluble to 20 mM in DMSO.

CHIR99021 (GSK3? kinase inhibitor)
SIH-437-5MG 5 mg
EUR 246
Description: The substance CHIR99021 is a gsk3? kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to light brown solid which is soluble to 20 mM in DMSO.

Gefitinib (EGFR Kinase inhibitor)
SIH-445-250MG 250 mg
EUR 360
Description: The substance Gefitinib is a egfr kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is solid which is soluble in DMSO (89 mg/ml at 25 °C), methanol (20 mg/ml), ethanol (4 mg/ml at 25 °C), DMF (20 mg/ml), and water (<1 mg/ml at 25 °C).

Gefitinib (EGFR Kinase inhibitor)
SIH-445-50MG 50 mg
EUR 164.4
Description: The substance Gefitinib is a egfr kinase inhibitor. It is synthetically produced and has a purity of >99%. The pure substance is solid which is soluble in DMSO (89 mg/ml at 25 °C), methanol (20 mg/ml), ethanol (4 mg/ml at 25 °C), DMF (20 mg/ml), and water (<1 mg/ml at 25 °C).

Axitinib (VEGFR kinase inhibitor)
SIH-494-10MG 10 mg
EUR 346.8
Description: The substance Axitinib is a vegfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to tan powder which is soluble to 25 mM in DMSO.

Casein Kinase II Inhibitor IV
HY-111378 10mM/1mL
EUR 590.4

STO 609 (CAMKK kinase inhibitor)
SIH-479-25MG 25 mg
EUR 474
Description: The substance STO 609 is a camkk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (10 mg/ml).

STO 609 (CAMKK kinase inhibitor)
SIH-479-5MG 5 mg
EUR 181.2
Description: The substance STO 609 is a camkk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (10 mg/ml).

ZM 306416 (VEGFR kinase inhibitor)
SIH-487-25MG 25 mg
EUR 474
Description: The substance ZM 306416 is a vegfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (3 mg/ml) or ethanol (1 mg/ml).

ZM 306416 (VEGFR kinase inhibitor)
SIH-487-5MG 5 mg
EUR 178.8
Description: The substance ZM 306416 is a vegfr kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is off-white solid which is soluble in DMSO (3 mg/ml) or ethanol (1 mg/ml).

Ruxolitinib (JAK kinase inhibitor)
SIH-509-25MG 25 mg
EUR 750
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

Ruxolitinib (JAK kinase inhibitor)
SIH-509-5MG 5 mg
EUR 285.6
Description: The substance Ruxolitinib is a jak kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is off-white solid which is soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml).

AG490 (JAK-2 kinase inhibitor)
SIH-428-25MG 25 mg
EUR 339.6
Description: The substance AG490 is a jak-2 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is tan solid which is soluble in DMSO (30 mg/ml), dimethyl formamide (40 mg/ml) or 100% ethanol (10 mg/ml).

AG490 (JAK-2 kinase inhibitor)
SIH-428-5MG 5 mg
EUR 158.4
Description: The substance AG490 is a jak-2 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is tan solid which is soluble in DMSO (30 mg/ml), dimethyl formamide (40 mg/ml) or 100% ethanol (10 mg/ml).

WHI P131 (JAK3 kinase inhibitor)
SIH-485-10MG 10 mg
EUR 178.8
Description: The substance WHI P131 is a jak3 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in DMSO (~1 mg/ml), and DMF (~1 mg/ml).

WHI P131 (JAK3 kinase inhibitor)
SIH-485-50MG 50 mg
EUR 460.8
Description: The substance WHI P131 is a jak3 kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to off-white solid which is soluble in DMSO (~1 mg/ml), and DMF (~1 mg/ml).

Apigenin (Protein kinase inhibitor)
SIH-249-10MG 10 mg
EUR 127.2
Description: The substance Apigenin is a protein kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 50 mM in DMSO.

Apigenin (Protein kinase inhibitor)
SIH-249-50MG 50 mg
EUR 255.6
Description: The substance Apigenin is a protein kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white solid which is soluble to 50 mM in DMSO.

ATM Kinase Inhibitor, KU-55933
1685-5 each
EUR 288

Adenosine Kinase Inhibitor (hydrate)
C5282-1 1 mg
EUR 134.4
Description: IC50: 1.7 nM in cell-free assaysAdenosine Kinase Inhibitor is an inhibitor of adenosine kinase. Adenosine kinase is the key metabolizing enzyme regulating cellular adenosine concentrations.

Adenosine Kinase Inhibitor (hydrate)
C5282-10 10 mg
EUR 435.6
Description: IC50: 1.7 nM in cell-free assaysAdenosine Kinase Inhibitor is an inhibitor of adenosine kinase. Adenosine kinase is the key metabolizing enzyme regulating cellular adenosine concentrations.

Adenosine Kinase Inhibitor (hydrate)
C5282-5 5 mg
EUR 360
Description: IC50: 1.7 nM in cell-free assaysAdenosine Kinase Inhibitor is an inhibitor of adenosine kinase. Adenosine kinase is the key metabolizing enzyme regulating cellular adenosine concentrations.

Diacylglycerol Kinase Inhibitor I
50R-R59022 50 mg
EUR 289.2
Description: Diacylglycerol Kinase Inhibitor I chemical reference substance

Dorsomorphin (AMPK kinase inhibitor)
SIH-443-25MG 25 mg
EUR 514.8
Description: The substance Dorsomorphin is a ampk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (4 mg/ml, warm).

Dorsomorphin (AMPK kinase inhibitor)
SIH-443-5MG 5 mg
EUR 184.8
Description: The substance Dorsomorphin is a ampk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is yellow solid which is soluble in DMSO (4 mg/ml, warm).

Imatinib mesylate (Kinase inhibitor)
SIH-453-100MG 100 mg
EUR 279.6
Description: The substance Imatinib mesylate is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige solid which is soluble H2O: soluble10 mg/ml, clear .

Imatinib mesylate (Kinase inhibitor)
SIH-453-20MG 20 mg
EUR 151.2
Description: The substance Imatinib mesylate is a kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white to beige solid which is soluble H2O: soluble10 mg/ml, clear .

BAY 11 7082 (IKK kinase inhibitor)
SIH-434-10MG 10 mg
EUR 184.8
Description: The substance BAY 11 7082 is a ikk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in ethanol and to 100 mM in DMSO.

BAY 11 7082 (IKK kinase inhibitor)
SIH-434-50MG 50 mg
EUR 507.6
Description: The substance BAY 11 7082 is a ikk kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is white solid which is soluble to 25 mM in ethanol and to 100 mM in DMSO.

PX 866 (PI 3-Kinase inhibitor)
SIH-471-1MG 1 mg
EUR 178.8
Description: The substance PX 866 is a pi 3-kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is crystalline solid which is soluble in DMSO at 200 mg/ml; soluble in ethanol at 200 mg/ml; very poorly soluble in water.

PX 866 (PI 3-Kinase inhibitor)
SIH-471-5MG 5 mg
EUR 298.8
Description: The substance PX 866 is a pi 3-kinase inhibitor. It is synthetically produced and has a purity of ?98%. The pure substance is crystalline solid which is soluble in DMSO at 200 mg/ml; soluble in ethanol at 200 mg/ml; very poorly soluble in water.

LY 294002 (PI 3-Kinase inhibitor)
SIH-252-25MG 25 mg
EUR 532.8
Description: The substance LY 294002 is a pi 3-kinase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is white crystalline solid which is soluble to 5 mM in ethanol and to 25 mM in DMSO.

Multi-ancestry genome-wide affiliation examine identifies 27 loci related to measures of hemolysis following blood storage

The evolutionary strain of endemic malaria and different erythrocytic pathogens has formed variation in genes encoding erythrocyte structural and purposeful proteins, influencing responses to hemolytic stress throughout transfusion and illness.
We sought to determine such genetic variants in blood donors by conducting a genome-wide affiliation examine (GWAS) of 12,353 volunteer donors, together with 1,483 African People, 1,477 Asians, and 960 Hispanics, whose saved erythrocytes have been characterised by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.
GWAS revealed 27 important loci (p<5×10-8), many in candidate genes identified to modulate erythrocyte construction, metabolism, and ion channels, together with SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/Band 3. GWAS of oxidative hemolysis recognized variants in antioxidant enzymes together with GLRX, GPX4, G6PD, and a novel golgi-transport protein SEC14L4.
Genome extensive important loci have been additionally examined for affiliation with the severity of regular state (baseline) in vivo hemolytic anemia in sufferers with sickle cell illness, with affirmation of recognized SNPs in HBA2, G6PD, PIEZO1, AQP1 and SEC14L4. Most of the recognized variants, equivalent to these in G6PD, have beforehand been proven to impair erythrocyte restoration after transfusion, affiliate with anemia, or trigger uncommon Mendelian human hemolytic illnesses.
Candidate SNPs in these genes, particularly in polygenic combos, could have an effect on RBC restoration after transfusion and modulate illness severity in hemolytic illnesses, equivalent to sickle cell illness and malaria.

Incorporating Genomic and Genetic Testing into the Therapy of Metastatic Luminal Breast Most cancers

Background: Therapy of sufferers with luminal metastatic breast most cancers (MBC) has turn out to be much more complicated over the previous few years as molecular profiling has begun to change illness administration. It’s properly accepted that MBC will not be curable however is treatable. Right now we’re capable of delay progression-free survival and partly total survival with focused and extra particular person therapy methods adjusted in keeping with the molecular subtype.
Abstract: Genetic and genomic testing has turn out to be therapeutically related in luminal MBC and is due to this fact an integral part inside the therapy spectrum. By now, germline testing of BRCABRCAPIK3CA mutations are inevitable parts in illness administration and the present state-of-the-art in luminal MBC sufferers.
Moreover, testing of ESR1 resistance mutation, ERBB2 mutation, microsatellite instability, and neurotrophic tyrosine receptor kinase (NTRK) gene fusion (primarily in secretory breast most cancers) has just lately gained growing consideration. Nonetheless, primarily based on the increasing function of personalised medication, clinicians are actually confronted with substantial new challenges and presumably unsuspected potentialities. The next evaluation summarizes present developments in genetic and genomic testing in luminal MBC.
Key messages: In luminal MBC genomics have turn out to be an integral part inside the spectrum of oncological therapy establishing novel therapeutic services. Additional developments in therapy personalization adjusted in keeping with the molecular subtype ought to turn out to be more and more necessary as a way to improve the progress of de-escalation of chemotherapy in luminal MBC. Nonetheless, primarily based on the increasing function of personalised medication, clinicians are actually confronted with substantial new challenges and presumably unsuspected potentialities.

HIV Type 1 p24 Antigen ELISA 2.0 (96 Determinations)
0801002 96T
EUR 603

HIV-1 p17-p24 recombinant antigen.
00172-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 p17-p24 recombinant antigen.

HIV-1 GAG P24 Recombinant Antigen
00111-V-01mg 0,1 mg
EUR 321
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 GAG P24 Recombinant Antigen
00111-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV 1 p24 core recombinant antigen
00177-V-01mg 0,1 mg
EUR 321
Description: HIV 1 p24 core recombinant antigen.

HIV 1 p24 core recombinant antigen
00177-V-1000ug 1000 ug
EUR 1539
Description: HIV 1 p24 core recombinant antigen.

HIV 1 p24 core recombinant antigen.
00177-V-100ugvial 100ug/vial
EUR 150
Description: HIV 1 p24 core recombinant antigen.

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)
0801200 5 X 96T
EUR 2563

HIV Type 1 p24 Antigen ELISA (5 X 96 Determinations)
801200 5 X 96 Determinations
EUR 2330

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)
801008 5 X 96 Determinations
EUR 2386

HIV Type 1 p24 Antigen ELISA 2.0 (5 X 96 Determinations)
0801008 5 X 96T
EUR 2505

Human HIV(1+2 antibodies plus p24 antigen (4th Generation) ELISA Kit
EH4101 96T
EUR 571.5
Description: Method of detection: Qualitative ;Reacts with: Homo sapiens;Sensitivity: Qualitative

HIV-1 p24 ELISA Kit
Z7040001 1 kit
EUR 752

HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa
00111-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa

HIV-1 p17/24/gp120 antigen
00169-V-01mg 0,1 mg
EUR 321
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV-1 p17/24/gp120 antigen
00169-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV-1 intergase antigen
00199-V-01mg 0,1 mg
EUR 321
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase).

HIV-1 intergase antigen
00199-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase).

HIV-1 p24 Antibody
20-abx137062
  • EUR 427.20
  • EUR 627.60
  • 0.5 mg
  • 1 mg

HIV-1 p24 Antibody
7313-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24 Antibody
7313-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix. The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein. The p24 is the major capsid protein of the virus and has been used in clinical trials as one of the components of the HIV-1 vaccine because of the high degree of sequence conservation between different strains.

HIV-1 p24 Antibody
abx021869-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody
abx021870-1mg 1 mg
EUR 760.8

HIV-1 p24 Antibody
abx021871-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody
abx021872-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody
abx021873-1mg 1 mg
EUR 794.4

HIV-1 p24 Antibody
abx021882-1mg 1 mg
EUR 1178.4

HIV-1 p24 Antibody
abx021883-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody
abx021886-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody
abx021887-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody
abx021888-1mg 1 mg
EUR 1220.4

HIV-1 p24 Antibody
abx023027-1ml 1 ml
EUR 693.6

HIV-1 p24 Antibody
abx023925-1mg 1 mg
EUR 828

HIV-1 p24 Antibody
abx023926-1mg 1 mg
EUR 828

HIV-1 p24
E5-00024 1mg
EUR 1152

HIV-1 p24
E62H002 100ug
EUR 458.4

HIV-1 p24
ant-152 0.5mg
EUR 275
Description: Mouse Anti HIV-1 p24

HIV-1 p24
hiv-006 100µg
EUR 130
Description: Recombinant HIV-1 p24

HIV-1 tat recombinant antigen
00110-V-01mg 0,1 mg
EUR 321
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 tat recombinant antigen
00110-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV-1 nef recombinant antigen
00112-V-01mg 0,1 mg
EUR 321
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 nef recombinant antigen
00112-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 gag recombinant antigen
8934 100 ug
EUR 542.86
Description: This is HIV-1 gag recombinant antigen for ELISA,WB.

HIV-1 nef recombinant antigen
8941 100 ug
EUR 477.6
Description: This is HIV-1 nef recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen,
00170-V-01mg 0,1 mg
EUR 321
Description: HIV-1 gp41 recombinant antigen.

HIV-1 gp41 recombinant antigen,
00170-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 gp41 recombinant antigen.

HIV-1 gp41 recombinant antigen
8908 100 ug
EUR 673.36
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen
8933 100 ug
EUR 477.6
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen
9000 100 ug
EUR 484.13
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen
9001 100 ug
EUR 484.13
Description: This is HIV-1 gp41 recombinant antigen for ELISA,WB.

HIV-1 gp41 recombinant antigen.
00170-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 gp41 recombinant antigen.

HIV p24 Antibody
abx021867-1mg 1 mg
EUR 1612.8

HIV p24 Antibody
abx021868-1mg 1 mg
EUR 1612.8

HIV-1 p17/24/gp120-gp41 recombinant antigen,
00168-V-01mg 0,1 mg
EUR 321
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV-1 p17/24/gp120-gp41 recombinant antigen,
00168-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV-1 p17/24/gp120-gp41 recombinant antigen.
00168-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 p17/24/gp120-gp41 recombinant antigen.

HIV-1 p24 Antibody (HRP)
abx023029-1ml 1 ml
EUR 886.8

HIV-1 p24 Antibody [8G9]
PM-6335-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9]
PM-6335-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]
PM-6585-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4]
PM-6585-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody (FITC)
abx021884-100ug 100 ug
EUR 886.8

HIV-1 p24 Antibody (FITC)
abx023026-1ml 1 ml
EUR 678

HIV 1 / 2 p24 Antibody
abx021866-1mg 1 mg
EUR 1212

HIV 1 / 2 p24 Antibody
abx021890-1mg 1 mg
EUR 1212

HIV-1 p24 Antibody (Biotin)
abx023028-1ml 1 ml
EUR 794.4

HIV 1 envelope recombinant antigen
00176-V-01mg 0,1 mg
EUR 321
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41.

HIV 1 envelope recombinant antigen
00176-V-1000ug 1000 ug
EUR 1539
Description: HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41.

Polyclonal HIV-1 p24 Antibody
APR11116G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HIV-1 p24 . This antibody is tested and proven to work in the following applications:

HIV-1 env gp41 recombinant antigen
00113-V-01mg 0,1 mg
EUR 321
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV-1 env gp41 recombinant antigen
00113-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV-1 p24 gag
hiv-123 100µg
EUR 165
Description: Recombinant HIV-I p24 gag

HIV-1 p24 His
hiv-159 5µg
EUR 60
Description: Recombinant HIV-1 p24 His Tag

HIV-1 gp41 Long recombinant antigen,
00171-V-01mg 0,1 mg
EUR 321
Description: HIV-1 gp41 Long recombinant antigen.

HIV-1 gp41 Long recombinant antigen,
00171-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 gp41 Long recombinant antigen.

HIV-1 gp41 Long recombinant antigen.
00171-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 gp41 Long recombinant antigen.

HIV-1 p24 24kDa
hiv-155 2µg
EUR 60
Description: Recombinant HIV-1 p24 , 24kDa

ToX Antigen (P24,GRA1)
E61Y00305 1mg
EUR 840

HIV-1 p24 Paired
ant-772 100µg
EUR 200
Description: Mouse Anti HIV-1 p24 Paired

HIV-1 p24 Protein
20-abx261886
  • EUR 5388.00
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

HIV-1 p24 Protein
abx169032-1mg 1 mg
EUR 661.2

HIV-1 p24 Protein
abx061424-05mg 0.5 mg
EUR 886.8

HIV-1, p24 Protein
abx069857-1mg 1 mg
EUR 1888.8

HIV-1 Gag p24
05-005 50 ug
EUR 434.4
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

HIV-1 Gag p24
05-006 250 ug
EUR 1154.4
Description: The HIV-1 Gag p24 is available in Europe and for worldwide shipping via Gentaur.

Recombinant HIV-1 p24
7-07603 100µg Ask for price

Recombinant HIV-1 p24
7-07604 500µg Ask for price

Recombinant HIV-1 p24
7-07605 1000µg Ask for price

HIV 1 p24 Protein
abx060589-1mg 1 mg
EUR 1545.6

HIV Type-1 p24 Antibody
V2344-100UG 100 ug
EUR 349.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344-20UG 20 ug
EUR 153.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344CF488-100T 100 Tests
EUR 349.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV Type-1 p24 Antibody
V2344SAF-100UG 100 ug
EUR 349.3
Description: Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immune deficiency syndrome (AIDS), a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections. HIV mainly infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages and dendritic cells. Two species of HIV infect humans: HIV-1 and HIV-2, with HIV-1 being the more virulent strain. The gag gene of human immunodeficiency virus 1 (HIV-1) encodes a precursor protein known as Pr55Gag. The viral protease PR cleaves this precursor to generate p17, p24, p7, and p6 proteins, which are required for virus particle assembly. HIV-1 Gag p24 is a capsid protein that constitutes the core of AIDS virus HIV-1. p6 and p7 are the components of the nucleocapsid, and p17 provides a protective matrix. HIV-1 Gag p24 is indispensable to the reproduction of AIDS virus and constitutes an essential element for the AIDS virus particle construction. As this protein is detectable from the early stage of AIDS virus infection, its measurement is commonly used as an indicator of HIV-1 infection and viral load.

HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.
00169-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120.

HIV type 1 P24
DAG1520 100 µg
EUR 972

HIV 1, 2 envelope recombinant antigen
00175-V-01mg 0,1 mg
EUR 321
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.

HIV 1, 2 envelope recombinant antigen
00175-V-1000ug 1000 ug
EUR 1539
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.

HIV-1 reverse transcriptase recombinant antigen
00198-V-01mg 0,1 mg
EUR 321
Description: HIV-1 reverse transcriptase recombinant antigen.

HIV-1 reverse transcriptase recombinant antigen
00198-V-1000ug 1000 ug
EUR 1539
Description: HIV-1 reverse transcriptase recombinant antigen.

HIV-1 reverse transcriptase recombinant antigen.
00198-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 reverse transcriptase recombinant antigen.

HIV-1 p24 Antibody [8G9] (HRP)
PM-6335-HRP-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (HRP)
PM-6335-HRP-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (HRP)
PM-6585-HRP-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (HRP)
PM-6585-HRP-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (biotin)
PM-6335-biotin-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [8G9] (biotin)
PM-6335-biotin-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (biotin)
PM-6585-biotin-002mg 0.02 mg
EUR 206.18
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

HIV-1 p24 Antibody [7F4] (biotin)
PM-6585-biotin-01mg 0.1 mg
EUR 523.7
Description: HIV-1 p24 Monoclonal Antibody: The human immunodeficiency virus type 1 (HIV-1) particle consists of an envelope, a core and the region between the two termed matrix (1). The HIV-1 Gag protein is a late structural protein that contains four proteins: matrix (p17), capsid (p24), nucleocapsid (p7) and the p6 protein (2). The p24 constitutes the major core component of the virus and shows high degree of sequence conservation among HIV isolates. The Gag p24 has been used as an integral part of multicomponent HIV-1 vaccines (3).

Feline Immunodeficiency Virus p24 Antigen (FIV p24) Antibody
abx411336-02mg 0.2 mg
EUR 710.4

Feline Immunodeficiency Virus p24 Antigen (FIV p24) Antibody
abx412988-2ml 2 ml
EUR 727.2

HIV-2 gp32 recombinant antigen
00173-V-01mg 0,1 mg
EUR 321
Description: HIV-2 gp32 recombinant antigen. .

HIV-2 gp32 recombinant antigen
00173-V-1000ug 1000 ug
EUR 1539
Description: HIV-2 gp32 recombinant antigen. .

HIV-2 gp36 recombinant antigen
8911 100 ug
EUR 673.36
Description: This is HIV-2 gp36 recombinant antigen for ELISA,WB.

HIV-2 gp36 recombinant antigen
8949 100 ug
EUR 529.8
Description: This is HIV-2 gp36 recombinant antigen for ELISA,WB.

HIV-2 gp36 recombinant antigen
9003 100 ug
EUR 484.13
Description: This is HIV-2 gp36 recombinant antigen for ELISA,WB.

HIV-2 gp32 recombinant antigen. .
00173-V-100ugvial 100ug/vial
EUR 150
Description: HIV-2 gp32 recombinant antigen. .

Polyclonal HIV-1 p24 Antibody [7F4]
APR11117G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Mouse that recognizes and binds to Human HIV-1 p24 [7F4] . This antibody is tested and proven to work in the following applications:

HIV-1 p24, His tag
E410A26-20 20μg
EUR 520.8

HIV-1 p24 Clone 91
ant-747 0.5mg
EUR 275
Description: Mouse Anti HIV-1 p24, Clone-91

HIV-1 p24 Clone 80
ant-748 0.5mg
EUR 275
Description: Mouse Anti HIV-1 p24, Clone-80

HIV type O envelope antigen
00178-V-01mg 0,1 mg
EUR 321
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence.

HIV type O envelope antigen
00178-V-1000ug 1000 ug
EUR 1539
Description: HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence.

HIV 2 gp36 envelope antigen
00180-V-01mg 0,1 mg
EUR 321
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36.

HIV 2 gp36 envelope antigen
00180-V-1000ug 1000 ug
EUR 1539
Description: HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36.

HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.
00175-V-100ugvial 100ug/vial
EUR 150
Description: HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide.

HIV-1 p24 Mouse mAb
E2210014-1D1 100ul
EUR 225
Description: Available in various conjugation types.

HIV-1 p24 Mouse mAb
E2210014-1F8 100ul
EUR 225
Description: Available in various conjugation types.

HIV-1 p24 Mouse mAb
E2210014-5B9 100ul
EUR 225
Description: Available in various conjugation types.

Mouse anti HIV-1 p24 McAb
E62H00502 100ug
EUR 225
Description: Available in various conjugation types.

Mouse anti HIV-1 p24 McAb
E62H00502a 1mg
EUR 1250
Description: Available in various conjugation types.

Mouse anti HIV-1 p24 McAb
E62H00503 100ug
EUR 225
Description: Available in various conjugation types.

Mouse anti HIV-1 p24 McAb
E62H00503a 1mg
EUR 1250
Description: Available in various conjugation types.

HIV-1 p24 Core Protein
20-abx260141
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Rabbitt anti HIV-1 p24 PcAb
E62H00501 100ug
EUR 225
Description: Available in various conjugation types.

Rabbitt anti HIV-1 p24 PcAb
E62H00501a 1mg
EUR 1250
Description: Available in various conjugation types.

Mouse antibody for HIV-1 p24
1941 100 ug
EUR 399.3
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1946 100 ug
EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1947 100 ug
EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1948 100 ug
EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Mouse antibody for HIV-1 p24
1949 100 ug
EUR 425.4
Description: This is purified Mouse monoclonal antibody against HIV-1 p24 for WB, ELISA.

Recombinant HIV-1 p24 Core
7-07597 100µg Ask for price

Recombinant HIV-1 p24 Core
7-07598 500µg Ask for price

Recombinant HIV-1 p24 Core
7-07599 1000µg Ask for price

HIV-1 p24 Core, (Recombinant)
22060211-1 100 µg
EUR 264.47

HIV-2 GP 36 Recombinant Antigen
00114-V-01mg 0,1 mg
EUR 321
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa

HIV-2 GP 36 Recombinant Antigen
00114-V-1000ug 1000 ug
EUR 1539
Description: HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa

Recombinant HIV-1 p24 , 24kDa
7-07621 2µg Ask for price

Recombinant HIV-1 p24 , 24kDa
7-07622 10µg Ask for price

Recombinant HIV-1 p24 , 24kDa
7-07623 100µg Ask for price

HIV-1 p24 Recombinant Protein
53-341 0.01 mg
EUR 789.9
Description: HIV-1 p24 Recombinant Protein

QuickTiter HIV Lentivirus Quantitation Kit (p24 ELISA)
VPK-108-H 96 assays
EUR 866.4
Description: Quantitation of the HIV-1 p24 core protein of a lentiviral vector is an efficient, well-published method for determining lentivirus physical titer. The QuickTiter Lentivirus Quantitation Kits provide a convenient method of p24 antigen quantitation.

QuickTiter HIV Lentivirus Quantitation Kit (p24 ELISA)
VPK-108-H-5 5 x 96 assays
EUR 3560.4
Description: Quantitation of the HIV-1 p24 core protein of a lentiviral vector is an efficient, well-published method for determining lentivirus physical titer. The QuickTiter Lentivirus Quantitation Kits provide a convenient method of p24 antigen quantitation.

HIV type 1 P24 [GST]
DAG1516 100 µg
EUR 774

HIV type 1 P24 [His]
DAG1518 100 µg
EUR 774

HIV type 1 P24 [His]
DAG1799 50 ug
EUR 2017.2

HIV type 1 P24 [His]
DAG2375 100 µg
EUR 868.8

HIV type 1 P24 [His]
DAG2377 100 µg
EUR 868.8

HIV type 1 p24 [FITC]
DAGH004 50 Tests
EUR 1112.4

HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa
00112-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa

HIV-1 p24 Immune Complex Dissociation Kit
Z7040009 1 kit
EUR 122

HIV type 1 P24 [Biotin]
DAG1519 100 µg
EUR 972

HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa
00113-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa

HIV-1 tat recombinant antigen full length 15 kDa
00110-V-100ugvial 100ug/vial
EUR 150
Description: HIV-1 tat recombinant antigen full length 15 kDa

HIV -2 env gp36 recombinant antigen
00179-V-01mg 0,1 mg
EUR 321
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702.

HIV -2 env gp36 recombinant antigen
00179-V-1000ug 1000 ug
EUR 1539
Description: HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702.

HIV p24 Mouse mAb
E2210005-10E7 100ul
EUR 225
Description: Available in various conjugation types.

HIV-1 gag p17, p24 Protein
20-abx260277
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

HIV-1 p24, 24 kDa Protein
20-abx263118
  • EUR 1562.40
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 10 ug
  • 2 µg

Recombinant HIV-1 gag p17, p24
7-07675 100µg Ask for price

Recombinant HIV-1 gag p17, p24
7-07676 500µg Ask for price

Recombinant HIV-1 gag p17, p24
7-07677 1000µg Ask for price

HIV-1 gag p17, p24 (Recombinant)
22060195-1 100 µg
EUR 264.47

HTLV-I p24 core recombinant antigen
00204-V-01mg 0,1 mg
EUR 321
Description: HLTV-I p24 core recombinant antigen.

HTLV-I p24 core recombinant antigen
00204-V-1000ug 1000 ug
EUR 1539
Description: HLTV-I p24 core recombinant antigen.

HLTV-I p24 core recombinant antigen.
00204-V-100ugvial 100 ug/vial
EUR 150
Description: HLTV-I p24 core recombinant antigen.

HIV-1 p24 Core, Sf9 Protein
20-abx260012
  • EUR 2815.20
  • EUR 493.20
  • EUR 276.00
  • 100 ug
  • 10 ug
  • 2 µg

Feline Immunodeficiency Virus p24 gag Antigen (FIV p24 gag) Antibody
abx413943-025mg 0.25 mg
EUR 811.2

Mouse Monoclonal Anti- HIV-1 p24 IgG
AB-15210 100 ug
EUR 416.4

Recombinant HIV-1 p24 His Tag
7-07606 5µg Ask for price

Recombinant HIV-1 p24 His Tag
7-07607 20µg Ask for price

Recombinant HIV-1 p24 His Tag
7-07608 1mg Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07602 100µg Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07600 2µg Ask for price

Recombinant HIV-1 p24 Core, Sf9
7-07601 10µg Ask for price

Recombinant Feline Immunodeficiency Virus p24 Antigen
E41H077 100ug
EUR 395

HIV-1 p24, Biotin Labeled Protein
20-abx260358
  • EUR 1496.40
  • EUR 560.40
  • EUR 2364.00
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant HIV-1 p24 Protein [His]
VAng-0527Lsx-inquire inquire Ask for price
Description: HIV type 1 P24 Antigen, recombinant protein from insect cell expression system.

HIV-1 gag p24 IIIB Protein
abx060586-05mg 0.5 mg
EUR 1128

Recombinant HIV-1 p24, Biotin Labeled
7-07612 100µg Ask for price

Recombinant HIV-1 p24, Biotin Labeled
7-07613 500µg Ask for price
Tags:, , , , , , , , , , , , , , , , , , , , , ,

Related Posts

About Author

Colin

Add a Comment

Your email address will not be published. Required fields are marked *